TCR2 THERAPEUTICS INC. Quarterly Preferred Stock, Par or Stated Value Per Share in USD/shares from Q4 2018 to Q1 2023

Taxonomy & unit
us-gaap: USD/shares
Description
Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.
Summary
Tcr2 Therapeutics Inc. quarterly Preferred Stock, Par or Stated Value Per Share history and growth rate from Q4 2018 to Q1 2023.
  • Tcr2 Therapeutics Inc. Preferred Stock, Par or Stated Value Per Share for the quarter ending March 31, 2023 was 0 USD/shares, unchanged year-over-year.
Preferred Stock, Par or Stated Value Per Share, Quarterly (USD/shares)
Preferred Stock, Par or Stated Value Per Share, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2023 $0 $0 0% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 $0 $0 0% Dec 31, 2022 10-Q 2023-05-11
Q3 2022 $0 $0 0% Sep 30, 2022 10-Q 2022-11-08
Q2 2022 $0 $0 0% Jun 30, 2022 10-Q 2022-08-08
Q1 2022 $0 $0 0% Mar 31, 2022 10-Q 2022-05-12
Q4 2021 $0 $0 0% Dec 31, 2021 10-K 2023-03-23
Q3 2021 $0 $0 0% Sep 30, 2021 10-Q 2021-11-10
Q2 2021 $0 $0 0% Jun 30, 2021 10-Q 2021-08-05
Q1 2021 $0 $0 0% Mar 31, 2021 10-Q 2021-05-13
Q4 2020 $0 $0 0% Dec 31, 2020 10-K 2022-03-22
Q3 2020 $0 $0 0% Sep 30, 2020 10-Q 2020-11-12
Q2 2020 $0 $0 0% Jun 30, 2020 10-Q 2020-08-12
Q1 2020 $0 $0 0% Mar 31, 2020 10-Q 2020-05-14
Q4 2019 $0 $0 0% Dec 31, 2019 10-K 2021-03-16
Q3 2019 $0 Sep 30, 2019 10-Q 2019-11-12
Q2 2019 $0 Jun 30, 2019 10-Q 2019-08-09
Q1 2019 $0 Mar 31, 2019 10-Q 2019-05-13
Q4 2018 $0 Dec 31, 2018 10-K 2020-03-30
* An asterisk sign (*) next to the value indicates that the value is likely invalid.